The preliminary financial results of Dr. Sulaiman Al Habib Medical Group revealed a 1.13% increase in net profits during the third quarter of 2025, due to increased revenues, on an annual basis. Net profits also increased by approximately 1.90% compared to the quarterly basis.
According to the company's preliminary financial statements released on Sunday on Tadawul, net profit after zakat and tax reached approximately 602.3 million riyals, compared to 595.54 million riyals in the comparative quarter of last year, while net profit for the second quarter of this year reached approximately 591.02 million riyals.
The company reported a 15.14% increase in earnings before interest, taxes, depreciation, and amortization (EBITDA) for the third quarter of 2025, reaching SAR 889.77 million, compared to SAR 772.75 million during the same quarter of the previous year. The profit margin remained stable at 25.69%.
Net income increased slightly during the third quarter of 2025 by 1.13%, reaching SAR 602.28 million, compared to SAR 595.54 million during the same quarter of the previous year.
This increase is attributed to revenue growth, noting that the new strategic expansions are still undergoing a phase of gradual revenue growth acceleration, while the fixed operating costs associated with these expansions have impacted profit margins until these hospitals gradually reach optimal operating capacity.
Revenues increased by 16.35% during the third quarter of 2025 to reach SAR 3.46 billion, compared to SAR 2.97 billion during the same quarter of the previous year, an increase of SAR 486.78 million.
This growth is primarily attributed to the performance of both the hospital and pharmacy sectors, as a result of increased visitor numbers and higher occupancy rates.
The company's net profits for the first nine months of this year reached approximately 1.75 billion riyals, compared to 1.70 billion riyals in the same period last year, an increase of 2.87%.
